Abstract:Generation of hiPSCs with multi‐gene modifications, including motor neuron‐specific transcription factors Ngn2, Isl1, and Lhx3 controlled by Tet‐On system and one anti‐apoptosis gene Bcl‐xL. The genetically modified hiPSCs survived and directionally differentiated into motor neurons after transplantation in vivo. The genetically modified hiPSCs partially converted into neural progenitors, serving as a spare cell resource. Objectives Transplantation of neural progenitor cells (NPCs) derived from human‐induced pluripotent stem cells (hiPSCs) is one of the promising treatment strategies for motor neuron diseases (MNDs). However, the inefficiency in committed differentiation of NPCs in vivo limits its application. Here, we tried to establish a potential therapeutic strategy for MNDs by in vivo directional differentiation of hiPSCs engineered with motor neuron (MN) specific transcription factors and Tet‐On system. Materials and Methods We engineered hiPSCs with three MN‐specific transcription factors and Tet‐On system. The engineered cells were directly transplanted into immunodeficient mice through subcutaneous, intra‐spinal cord and intracerebroventricular injections. Following doxycycline (Dox) induction, teratoma formation, and motor MN differentiation were evaluated. Results We generated genetically engineered hiPSCs, in which the expression of Ngn2, Isl1, and Lhx3 was controlled by a drug‐inducible transgenic system. These cells showed normal pluripotency and proliferative capacity, and were able to directionally differentiate into mature motor neurons (MNs) and NPCs with high efficiency in spinal cords and cerebral lateral ventricles under the induction of Dox. The grafts showed long‐term survival in the recipient mice without formation of teratoma. Conclusions The induced mature MNs and NPCs were expected to replace the damaged endogenous MNs directly, and play a role of de novo stem cell stock for long‐term neuron damage repair, respectively. Therefore, in vivo directional differentiation of the hiPSCs engineered with MN‐specific transcription factors and Tet‐On system via Dox induction could be a potential therapeutic strategy for MNDs with high efficacy and safety.

Comparison of two methods for teaching therapists to score the test of infant motor performance.

Induced Neural Stem/precursor Cells for Fundamental Studies and Potential Application in Neurodegenerative Diseases

Dopaminergic precursors differentiated from human blood-derived induced neural stem cells improve symptoms of a mouse Parkinson's disease model

Extracts of muscle from amyotrophic lateral sclerosis: effect on cultured neuron.

Direct Reprogramming of Mouse Fibroblasts to Neural Progenitors

Redefining Parkinson’s Disease Research Using Induced Pluripotent Stem Cells

Therapeutic function of a novel rat induced pluripotent stem cell line in a 6‑OHDA‑induced rat model of Parkinson's disease

Dopamine Release from Transplanted Neural Stem Cells in Parkinsonian Rat Striatum in Vivo.

Generation of naivetropic induced pluripotent stem cells from Parkinson's disease patients for high efficiency genetic manipulation

The Long-Term Survival and Functional Maturation of Human Inpc-Derived Neurons in the Basal Forebrain of Cynomolgus Monkeys

Tracking Induced Pluripotent Stem Cells-Derived Neural Stem Cells in the Central Nervous System of Rats and Monkeys.

Generation of surface acoustic waves in silicon with energetic femtosecond laser pulses

In Vitro Induction of Mouse Meningeal-Derived Ips Cells into Neural-Like Cells

Direct Reprogramming of Mouse Fibroblasts to Neural Stem Cells by Small Molecules

Direct reprogramming of Sertoli cells into multipotent neural stem cells by defined factors

Rescue Of Dopamine Release And Behavior By Transplanted Neural Stem Cells In A Rat Model Of Parkinsonism

Inducible motor neuron differentiation of human induced pluripotent stem cells in vivo

Conversion of Human Fibroblasts into Induced Neural Stem Cells by Small Molecules

Induced pluripotent stem cell-derived neural cells survive and mature in the nonhuman primate brain.

Human iPS cell-derived dopaminergic neurons function in a primate Parkinson’s disease model

Human neural stem cells promote mitochondrial genesis to alleviate neuronal damage in MPTP-induced cynomolgus monkey models